Key statistics
On Friday, Rocket Pharmaceuticals Inc (9IP1:FRA) closed at 14.18, 0.00% above its 52-week low of 14.18, set on Oct 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.18 |
---|---|
High | 14.18 |
Low | 14.18 |
Bid | 14.92 |
Offer | 14.98 |
Previous close | 14.96 |
Average volume | 178.20 |
---|---|
Shares outstanding | 90.98m |
Free float | 86.62m |
P/E (TTM) | -- |
Market cap | 1.49bn USD |
EPS (TTM) | -2.79 USD |
Data delayed at least 15 minutes, as of Oct 04 2024 07:13 BST.
More ▼
Press releases
- Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease
- Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
- Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
- Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress